The following excerpt is from an article that originally appeared on Hit and Run Reason
BILL GREENBLATT/UPI/NewscomPresident Trump will appoint former drug company president and government health official Alex Azar to lead the Department of Health and Human Services (HHS).
Until January of this year, Azar, who was trained as a lawyer and clerked for several conservative judges, was president of Lilly USA, an affiliate of Eli Lilly and Co. focused on treating diabetes. Azar also served as general counsel and deputy secretary of HHS during the George W. Bush administration. Here’s what you can expect as his nomination moves forward.
Happy to announce, I am nominating Alex Azar to be the next HHS Secretary. He will be a star for better healthcare and lower drug prices!
— Donald J. Trump (@realDonaldTrump) November 13, 2017
Because of his work for a pharmaceutical company, and because of some of President Trump’s past remarks, Azar’s nomination will inevitably raise policy questions about prescription drug prices.
Trumppost was originally published on this site